Heartbeam Inc (BEAT) Stock Price, Quote & News

Latest News on BEAT

Mar 13, 2025, 9:02 PM EDT - 20 days ago

HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 4:01 PM EDT - 20 days ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 27 days ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 4 weeks ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 5 weeks ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 6 weeks ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 2 months ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 3 months ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 3 months ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 4 months ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 9, 2024, 9:22 PM EST - 5 months ago

HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 5 months ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 5 months ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 5 months ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 5 months ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Sep 24, 2024, 8:31 AM EDT - 6 months ago

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Sep 10, 2024, 8:31 AM EDT - 7 months ago

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Aug 14, 2024, 8:51 PM EDT - 8 months ago

HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 8 months ago

HeartBeam Reports Second Quarter 2024 Results

Aug 1, 2024, 8:31 AM EDT - 8 months ago

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

Jul 1, 2024, 8:31 AM EDT - 9 months ago

HeartBeam Added to Russell Microcap® Index

Jun 25, 2024, 9:00 AM EDT - 10 months ago

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

May 20, 2024, 8:31 AM EDT - 11 months ago

HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

May 13, 2024, 8:31 AM EDT - 11 months ago

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

May 12, 2024, 10:36 AM EDT - 11 months ago

HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 11 months ago

HeartBeam Reports First Quarter 2024 Results

Apr 25, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

Apr 9, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

Mar 20, 2024, 7:35 PM EDT - 1 year ago

HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 4:05 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 14, 2024, 8:31 AM EDT - 1 year ago

First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG

Mar 7, 2024, 8:31 AM EST - 1 year ago

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

Mar 5, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

Dec 14, 2023, 8:31 AM EST - 1 year ago

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

Nov 14, 2023, 7:10 PM EST - 1 year ago

HeartBeam, Inc. (BEAT) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:01 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 8:31 AM EST - 1 year ago

HeartBeam Announces Expansion of Its Scientific Advisory Board

Nov 7, 2023, 8:31 AM EST - 1 year ago

HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias

Oct 31, 2023, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time

Sep 27, 2023, 8:05 AM EDT - 1 year ago

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer

Sep 26, 2023, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team

Aug 13, 2023, 1:03 PM EDT - 1 year ago

HeartBeam, Inc. (BEAT) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:01 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2023 Financial Results

Aug 9, 2023, 8:31 AM EDT - 1 year ago

HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks

Aug 8, 2023, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs

Jul 27, 2023, 8:31 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time

Jul 26, 2023, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors

Jun 8, 2023, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors

May 30, 2023, 8:00 AM EDT - 2 years ago

HeartBeam Enters into Strategic Alliance Agreement with Samsung

May 25, 2023, 8:31 AM EDT - 2 years ago

Market Cap	67.45M
Revenue (ttm)	0.00
Net Income (ttm)	-19.45M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	49,800
Avg Vol	92,074
Day's Range	N/A - N/A
Shares Out	33.73M
Stochastic %K	76%
Beta	-0.60
Analysts	Sell
Price Target	$8.00